ABSTRACT
Objectives Guatemala faces a significant challenge with one of the lowest voluntary blood donation rates in Latin America, a problem further exacerbated by the COVID-19 pandemic. This study aimed to investigate the population factors influencing blood donation behavior in Guatemala during the COVID-19 pandemic.
Methods Conducted between August and September 2020, this cross-sectional electronic anonymous survey employed purposive sampling. Participants were questioned about their donation history, knowledge of donation processes, preferences, and barriers and motivators for blood donation. Quantitative and qualitative data were collected and analyzed.
Comparative analyses were conducted based on gender, age, and education level. Regression analysis was used to identify predictors of blood donation behavior. Open-ended responses were studied via thematic content analysis.
Results Among the 1141 respondents, 53.5% reported a history of blood donation. Most donations occurred via referred donations to family or friends (78.5%). Factors such as male gender, older age, and higher education were associated with previous blood donation.
Familiarity with donation centers and willingness to donate strongly influenced donation behavior. Among never donors, 89% expressed willingness to donate. Constraints in accessing donation centers, limited operation hours, insufficient knowledge about the donation process, and concerns over hygiene and safety were identified as the most prevalent barriers to donation.
Conclusions Respondents demonstrated a strong willingness to donate blood voluntarily. Understanding demographic and population factors is critical to inform tailored initiatives to facilitate access to voluntary blood donation in Guatemala.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research was approved by the Harvard Longwood Campus Institutional Review Board under protocol IRB 23-0135.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Footnotes
josecarlosmonzon{at}hotmail.com
isabellaxfaria{at}gmail.com
shreenikkundu{at}gmail.com
azileali{at}pennstatehealth.psu.edu
rjhunjhu{at}bidmc.harvard.edu
nraykar{at}bwh.harvard.edu
sabrinaa{at}ufm.edu
Data Availability
The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.
